LSE:RENX (Renalytix AI plc)

About RENX

Renalytix LSE: RENX NASDAQ: RNLX is the founder and global leader in the new field of bioprognosis for kidney health. Weve engineered a proprietary solution that successfully enables early-stage progression risk assessment when it counts the most. Renalytix. Right here until kidney disease isnt.